Notice of Intent to Sole Source – Becton, Dickinson and Company
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the Clinical Center (CC), has issued a Notice of Intent to Sole Source a 3-year service contract to Becton, Dickinson and Company (BD). This contract is for the maintenance and support of BD Lyse/Wash Assistants (LWAs) and a BD FACSMelody cell sorter at the NIH Center for Cellular Engineering (CCE) in Bethesda, MD. Interested parties may identify their capabilities in response to this notice.
Scope of Work
The acquisition is for a 3-year service contract covering:
- Preventive maintenance for two BD Lyse/Wash Assistants (LWAs).
- Preventive maintenance for one BD FACSMelody cell sorter.
- Emergency servicing for the specified equipment.
This support is crucial for ongoing protocols at the NIH Center for Cellular Engineering (CCE) at the Clinical Center (CC).
Contract Details
- Type: Notice of Intent to Sole Source (Fixed-Price Purchase Order)
- Intended Awardee: Becton, Dickinson and Company (BD)
- Duration: 3 years
- Set-Aside: None (Sole Source)
- NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
- Product Service Code (PSC): 6515 – Medical Instruments, Equipment, and Supplies
- Place of Performance: Bethesda, MD 20892, USA
Justification for Sole Source
The NIH intends to award this contract to BD on a sole source basis due to specific circumstances:
- BD is the only entity capable of providing the necessary preventive maintenance and emergency servicing for their proprietary equipment.
- The quality of product required (per FDA standards) for ongoing protocols necessitates BD's involvement.
- The urgency of the requirement limits competition.
This acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which allows for sole source awards when only one source is reasonably available for purchases not exceeding the simplified acquisition threshold.
Response & Deadline
This is a Notice of Intent, not a request for quotation, and a solicitation document will not be issued. However, interested parties may identify their interest and capabilities in response to this posting. The Government retains discretion regarding competition based on responses.
- Response Due: June 4, 2026, at 12:00 PM EST
- Submit to: Kristin Nagashima, Contract Specialist, via email at Kristin.nagashima@nih.gov
- Published: May 28, 2026